These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18684744)

  • 41. [A comparative study of conventional dose and low dose adrenocorticotrophic hormone therapy for West syndrome].
    Shu XM; Li J; Zhang GP; Mao Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):445-8. PubMed ID: 19558807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].
    Adam Z; Krejcí M; Pour L; Neubauer J; Prásek J; Hájek R
    Vnitr Lek; 2008 Dec; 54(12):1140-53. PubMed ID: 19140523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know.
    Dixon WG; Bansback N
    Ann Rheum Dis; 2012 Nov; 71(11):1761-4. PubMed ID: 22851467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.
    Santiago T; Jacobs JW; Saag KG; Buttgereit F; Pereira da Silva JA
    Acta Reumatol Port; 2015; 40(1):10-22. PubMed ID: 25844966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin-associated adverse cognitive effects: survey results from 171 patients.
    Evans MA; Golomb BA
    Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy.
    Arena C; Morin AS; Blanchon T; Hanslik T; Cabane J; Dupuy A; Fardet L
    Br J Dermatol; 2010 Oct; 163(4):832-7. PubMed ID: 20518780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients.
    Morin C; Fardet L
    Clin Rheumatol; 2015 Dec; 34(12):2119-26. PubMed ID: 25956956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developments in glucocorticoid therapy.
    Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
    Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long-term glucocorticoid therapy : Is there a safe dosage?].
    Strehl C; Buttgereit F
    Internist (Berl); 2016 Sep; 57(9):934-9. PubMed ID: 27351788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoids in early rheumatoid arthritis.
    Davey M; Buchbinder R
    Aust Fam Physician; 2008; 37(1-2):31-2. PubMed ID: 18239749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients.
    Olivieri O; Pizzolo F; Ravagnani V; Moretti L; Carletto A; Faccini G; Pasini F; Friso S; Corrocher R
    J Hypertens; 2008 Mar; 26(3):486-93. PubMed ID: 18300859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
    Binard A; De Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?
    Buttgereit F; Burmester G; Bijlsma JW
    Ann Rheum Dis; 2005 Jan; 64(1):171-2; author reply 172. PubMed ID: 15608329
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of glucocorticoids on the neutrophil count: a cohort study among hospitalized patients.
    Velthove KJ; Leufkens HG; Souverein PC; Schweizer RC; Bracke M; van Solinge WW
    Pulm Pharmacol Ther; 2010 Apr; 23(2):129-34. PubMed ID: 19879372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.
    Strehl C; Bijlsma JW; de Wit M; Boers M; Caeyers N; Cutolo M; Dasgupta B; Dixon WG; Geenen R; Huizinga TW; Kent A; de Thurah AL; Listing J; Mariette X; Ray DW; Scherer HU; Seror R; Spies CM; Tarp S; Wiek D; Winthrop KL; Buttgereit F
    Ann Rheum Dis; 2016 Jun; 75(6):952-7. PubMed ID: 26933146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort study.
    Fardet L; Nazareth I; Petersen I
    Rheumatology (Oxford); 2021 Mar; 60(3):1502-1511. PubMed ID: 32864693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How should rheumatologists prescribe low-dose glucocorticoids?
    Palazzo E
    Rev Rhum Engl Ed; 1999 Mar; 66(3):127-30. PubMed ID: 10327489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.